E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/29/2005 in the Prospect News Biotech Daily.

LAB kept by Jennings at speculative buy

LAB International Inc. was maintained by Jennings Capital analyst Shameze Rampertab at a speculative buy rating with a price target on the stock of C$2.75 following second-quarter results. LAB shares on the Toronto stock exchange Friday fell C$0.14, or 14.74%, to close at C$0.81 on volume of 12,400 shares versus the three-month running average of 39,438.5 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.